In addition, we have shown that this treatment is also efficacious in patient-derived spheroids derived from human NB specimens [50], providing a proof of principle for the potential of the proposed combinatorial strategy to recruit and activate CD8+ T cells and NK cells in a patient-specific context [47]. This evidence concerns the gene CD8A and neuroblastoma.